Anavex Life Sciences
Anavex Life Sciences Corp. is a biopharmaceutical company based in New York, NY, dedicated to developing novel small molecule treatments for challenging central nervous system diseases such as Alzheimer's disease, Parkinson's disease, and rare conditions like Rett syndrome. Through its proprietary SIGMACEPTOR platform, the company targets the Sigma-1 receptor (SIGMAR1) to potentially enhance the body's own defenses against neurodegeneration.
With an emphasis on precision medicine, Anavex focuses on addressing the needs of patients and caregivers affected by neurodegenerative and neurodevelopmental disorders. Their investigational drug, ANAVEX 2-73 (blarcamesine), aims to improve autophagy and restore neural cell homeostasis, with ongoing efforts to engage with the community and ensure access to new treatment paradigms.
Generated from the website
Also at this address
You might also like
Partial Data by Foursquare.